Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review

References

• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014. https://doi.org/10.3389/fphar.2013.00177.
   PubMed Web of Science ®Google Scholar
• Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health. 2002;92(10):1582–1591.
   PubMed Web of Science ®Google Scholar
• Hensel K. Dietary and herbal supplements. National Center for Complementary and Integrative Health. U.S. Department of Health and Human Services. 2020. https://www.nccih.nih.gov/health/dietary-and-herbal-supplements. Accessed 28 Sept 2020.
   Google Scholar
• FDA 101: dietary supplements. U.S. Food and Drug Administration. 2015. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements. Accessed 28 Sept 2020.
   Google Scholar
• Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–361. https://doi.org/10.1001/jamainternmed.2013.2299.
   PubMed Web of Science ®Google Scholar
• Laeeque H, Boon H, Kachan N, Cohen JC, D’Cruz J. The Canadian natural health products (NHP) regulations: industry perceptions and compliance factors. BMC Health Serv Res. 2006;6(1):1–11. https://doi.org/10.1186/1472-6963-6-63.
   PubMedGoogle Scholar
• Awodele O, Amagon KI, Wannang NN, Aguiyi JC. Traditional medicine policy and regulation in Nigeria: an index of herbal medicine safety. Curr Drug Saf. 2014;9(1):16–22. https://doi.org/10.2174/1574886308666131126155434.
   PubMedGoogle Scholar
• Fung FY, Linn YC. Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges. Evid Based Complement Alternat Med. 2015;2015:1–9. https://doi.org/10.1155/2015/425037.
   Web of Science ®Google Scholar
• Ndeinoma A, Wiersum KF, Arts B. The governance of indigenous natural products in Namibia: a policy network analysis. Environ Manag. 2018;62(1):29–44. https://doi.org/10.18174/460577.
   PubMed Web of Science ®Google Scholar
• Barry AR. Patients’ perceptions and use of natural health products. Can Pharm J. 2018;151(4):254–262. https://doi.org/10.1177/1715163518779409.
   Web of Science ®Google Scholar
• Ronis MJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annu Rev Pharmacol Toxicol. 2018;58:583–601. https://doi.org/10.1146/annurev-pharmtox-010617-052844.
   PubMed Web of Science ®Google Scholar
• Asher GN, Corbett AH, Hawke RL. Common herbal dietary supplement–drug interactions. Am Fam Physician. 2017;96(2):101–107.
   PubMed Web of Science ®Google Scholar
• Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363–373. https://doi.org/10.1002/hep.28813.
   PubMed Web of Science ®Google Scholar
• Binns C, Lee M, Lee A. Problems and prospects: public health regulation of dietary supplements. Annu Rev Public Health. 2018;39(1):403–420. https://doi.org/10.1146/annurev-publhealth-040617-013638.
   PubMedGoogle Scholar
• Smith A, Jogalekar S, Gibson A. Regulation of natural health products in Canada. J Ethnopharmacol. 2014;158:507–510. https://doi.org/10.1016/j.jep.2014.06.037.
   PubMed Web of Science ®Google Scholar
• An overview of the regulation of complementary medicines in Australia. Australian Government Department of Health. 2013. https://www.tga.gov.au/overview-regulation-complementary-medicines-australia. Accessed 18 Oct 2020.
   Google Scholar
• WHO traditional medicine strategy: 2014–2023. World Health Organization. 2013. https://www.who.int/publications-detail-redirect/9789241506096. Accessed 18 Oct 2020.
   Google Scholar
• Alostad AH, Steinke DT, Schafheutle EI. A qualitative exploration of Bahrain and Kuwait herbal medicine registration systems: policy implementation and readiness to change. J Pharm Policy Pract. 2019;12(1):1–20. https://doi.org/10.1186/s40545-019-0189-7.
   PubMedGoogle Scholar
• Routledge PA. The European herbal medicines directive: could it have saved the lives of Romeo and Juliet? Drug Saf. 2008;31(5):416–418. https://doi.org/10.2165/00002018-200831050-00006.
   PubMed Web of Science ®Google Scholar
• Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med. 2011;9(1):1–9. https://doi.org/10.1186/1741-7015-9-94.
   PubMedGoogle Scholar
• Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005. https://doi.org/10.1080/1364557032000119616.
   Google Scholar
• Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010. https://doi.org/10.1186/1748-5908-5-69.
   PubMed Web of Science ®Google Scholar
• Ruheel MA, Gomes Z, Usman S, et al. Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literature. Harm Reduct J. 2021;18:106. https://doi.org/10.1186/s12954-021-00547-8.
   Google Scholar
• Sahoo N, Manchikanti P. Herbal drug regulation and commercialization: an Indian industry perspective. J Altern Complement Med. 2013;19(12):957–963. https://doi.org/10.1089/acm.2012.0275.
   PubMed Web of Science ®Google Scholar
• Appiah B, Amponsah IK, Poudyal A, Mensah MLK. Identifying strengths and weaknesses of the integration of biomedical and herbal medicine units in Ghana using the WHO health systems framework: a qualitative study. BMC Complement Altern Med. 2018;18(1):286. https://doi.org/10.1186/s12906-018-2334-2.
   PubMed Web of Science ®Google Scholar
• Carvalho ACB, Ramalho LS, de OliveiraMarques RF, Perfeito JPS. Regulation of herbal medicines in Brazil. J Ethnopharmacol. 2014;158(Pt B):503–506. https://doi.org/10.1016/j.jep.2014.08.019.
   PubMedGoogle Scholar
• Alameddine M, Naja F, Abdel-Salam S, Maalouf S, Matta C. Stakeholders’ perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study. BMC Complement Altern Med. 2011;11:71. https://doi.org/10.1186/1472-6882-11-71.
   PubMed Web of Science ®Google Scholar
• Alostad AH, Steinke DT, Schafheutle EI. International comparison of five herbal medicine registration systems to inform regulation development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain. Pharmaceut Med. 2018;32(1):39–49. https://doi.org/10.1007/s40290-018-0223-0.
   PubMed Web of Science ®Google Scholar
• Walji R, Wiktorowicz M. Governance of natural health products regulation: an iterative process. Health Policy. 2013;111(1):86–94. https://doi.org/10.1016/j.healthpol.2013.02.011.
   PubMed Web of Science ®Google Scholar
• Moss K, Boon H, Ballantyne P, Kachan N. New Canadian natural health product regulations: a qualitative study of how CAM practitioners perceive they will be impacted. BMC Complement Altern Med. 2006;6(1):1–8. https://doi.org/10.1186/1472-6882-6-18.
   PubMedGoogle Scholar
• Moss K, Boon H, Ballantyne P, Kachan N. The professionalization of Western herbalists: response to new product regulations in Canada. Complement Ther Med. 2007;15(4):264–270. https://doi.org/10.1016/j.ctim.2007.01.007.
   PubMed Web of Science ®Google Scholar
• Carvalho ACB, Lana TN, Perfeito JPS, Silveira D. The Brazilian market of herbal medicinal products and the impacts of the new legislation on traditional medicines. J Ethnopharmacol. 2018;212:29–35. https://doi.org/10.1016/j.jep.2017.09.040.
   PubMed Web of Science ®Google Scholar
• Molin TRD, Leal GC, Müller LS, Muratt DT, Marcon GZ, de Carvalho LM,et al. Regulatory framework for dietary supplements and the public health challenge. Rev Saude Publica. 2019;53:90. https://doi.org/10.11606/s1518-8787.2019053001263.
   PubMed Web of Science ®Google Scholar
• Justa Neves DB, Caldas ED. Dietary supplements: international legal framework and adulteration profiles, and characteristics of products on the Brazilian clandestine market. Regul Toxicol Pharmacol. 2015;73(1):93–104. https://doi.org/10.1016/j.yrtph.2015.06.013.
   PubMed Web of Science ®Google Scholar
• Dwyer JT, Coates PM, Smith MJ. Dietary supplements: regulatory challenges and research resources. Nutrients. 2018;10(1):41. https://doi.org/10.3390/nu10010041.
   PubMed Web of Science ®Google Scholar
• Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol. 2013;69:295–307. https://doi.org/10.1007/s00228-012-1353-z.
   Google Scholar
• Zhou X, Li C-G, Chang D, Bensoussan A. Current status and major challenges to the safety and efficacy presented by Chinese herbal medicine. Medicines. 2019;6(1):14. https://doi.org/10.3390/medicines6010014.
   Google Scholar
• Sharma S. Current status of herbal product: regulatory overview. J Pharm Bioallied Sci. 2015;7(4):293. https://doi.org/10.4103/0975-7406.168030.
   PubMed Web of Science ®Google Scholar
• Pandey MM, Rastogi S, Rawat AK. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med. 2013;2013:1–12. https://doi.org/10.1155/2013/376327.
   Web of Science ®Google Scholar
• Verma N. Current regulatory challenges and approaches in the registration of herbal drugs in Europe. Clin Res Regul Aff. 2016;33(1):9–24. https://doi.org/10.3109/10601333.2016.1130717.
   Google Scholar
• Qu L, Zou W, Wang YT, Wang M. European regulation model for herbal medicine: the assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in member states. Phytomedicine. 2018;42:219–225. https://doi.org/10.1016/j.phymed.2018.03.048.
   PubMed Web of Science ®Google Scholar
• Kumar V. An overview of herbal medicine. Int J Pharm Sci. 2009;1(1):1–20.
   Google Scholar
• Shipkowski KA, Betz JM, Birnbaum LS, Bucher JR, Coates PM, Hopp DC, et al. Naturally complex: perspectives and challenges associated with botanical dietary supplement safety assessment. Food Chem Toxicol. 2018;118:963–971. https://doi.org/10.1016/j.fct.2018.04.007.
   PubMed Web of Science ®Google Scholar
• Palhares RM, Gonçalves Drummond M, dos Santos Alves FigueiredoBrasil B, Pereira Cosenza G, das GraçasLinsBrandão M, Oliveira G. Medicinal plants recommended by the World Health Organization: DNA barcode identification associated with chemical analyses guarantees their quality. PLoS ONE. 2015;10(5): e0127866. https://doi.org/10.1371/journal.pone.0127866.
   PubMed Web of Science ®Google Scholar
• Reis CP, Gouveia BG, Rijo P, Gonçalo TS. Good manufacturing practices for medicinal products for human use. J Pharm Bioallied Sci. 2015;7(2):87. https://doi.org/10.4103/0975-7406.154424.
   PubMedGoogle Scholar
• Starr RR. Too little, too late: ineffective regulation of dietary supplements in the United States. Am J Public Health. 2015;105(3):478–485. https://doi.org/10.2105/AJPH.2014.302348.
   PubMed Web of Science ®Google Scholar
• Denham BE. Dietary supplements—regulatory issues and implications for public health. JAMA. 2011;306(4):428–429. https://doi.org/10.1001/jama.2011.982.
   PubMed Web of Science ®Google Scholar
• Sharma AK, Kumar R, Mishra A, Gupta R. Problems associated with clinical trials of ayurvedic medicines. Rev Bras Farmacogn. 2010;20(2):276–281. https://doi.org/10.1590/S0102-695X2010000200023.
   Web of Science ®Google Scholar
• Paller CJ, Denmeade SR, Carducci MA. Challenges of conducting clinical trials of natural products to combat cancer. Clin Adv Hematol Oncol. 2016;14(6):447–455.
   PubMedGoogle Scholar
• Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114: 104647. https://doi.org/10.1016/j.yrtph.2020.104647.
   PubMed Web of Science ®Google Scholar
• Clark AM, Zorn KM, Lingerfelt MA, Ekins S. Developing next generation tools for computational toxicology. Comput Toxicol. 2018. https://doi.org/10.1002/9781119282594.ch14.
   Google Scholar
• Gesto-Borroto R, Medina-Jiménez K, Lorence A, Villarreal ML. Application of DNA barcoding for quality control of herbal drugs and their phytopharmaceuticals. Rev Bras Farmacogn. 2021;31(2):127–141. https://doi.org/10.1007/s43450-021-00128-7.
   Google Scholar